Title: Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
Publisher: NEJM
Publication Date: 07 May 2020
URL: https://www.nejm.org/doi/pdf/10.1056/NEJMoa2006923
Key Takeaways: As you saw in last week’s Intelligence Report, there has been a debate over the association of ACE inhibitors and increased risk of developing COVID or having a more severe disease course. This large observational study does not support this theory and supports the safety of using ACE inhibitors in COVID patients.